Skip to main content
. 2024 Jun 6;14:13028. doi: 10.1038/s41598-024-62864-9

Figure 2.

Figure 2

Design route of benzenesulfonamide-based targets bearing azido group in 3, 4 or 1,2,3-triazole-glycoside scaffolds in 6–13 targeting VEGFR-2 and Carbonic anhydrase inhibition.